Loading clinical trials...
Loading clinical trials...
A Randomized, Double-Blind Study to Assess the Efficacy of Tacrolimus (Prograf®)+ Methotrexate Vs. Placebo + Methotrexate in the Treatment of Rheumatoid Arthritis in Patients With Partial Response to Methotrexate
Conditions
Interventions
Tacrolimus (Prograf®)
Methotrexate
Locations
45
United States
University of Alabama at Birmingham
Birmingham, Alabama, United States
Rheumatology Associates of North Alabama
Huntsville, Alabama, United States
Radiant Research, Pharmaceutical Clinical Trials Division
Scottsdale, Arizona, United States
Boling Clinical Trials
Rancho Cucamonga, California, United States
San Diego Arthritis & Osteoporosis Medical Clinic
San Diego, California, United States
Pacific Arthritis Center and Medical Group
Santa Maria, California, United States
Start Date
March 1, 2002
Completion Date
January 1, 2004
Last Updated
March 27, 2012
NCT06647069
NCT07484243
NCT06841562
NCT07268326
NCT07233655
NCT07029555
Lead Sponsor
Astellas Pharma Inc
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions